Filtered By:
Vaccination: Covid Vaccine

This page shows you your search results in order of relevance. This is page number 13.

Order by Relevance | Date

Total 848 results found since Jan 2013.

Effectiveness of Coronavirus Vaccines against Syndrome Coronavirus 2 (SARS-CoV-2) and Its New Variants
Iran J Allergy Asthma Immunol. 2021 Dec 8;20(6):647-671. doi: 10.18502/ijaai.v20i6.8016.ABSTRACTThe widespread outbreak of coronavirus disease 2019 in late 2019 caused many people worldwide to die or suffer from certain clinical complications even after the recovery. The virus has many social and economic adverse effects. Studies on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have specified that spike, surface glycoprotein antigen, is considered as a major target to stimulate the immune system. This glycoprotein binds to the angiotensin-converting enzyme 2 on the surface of human cells especially lung epit...
Source: Iranian Journal of Allergy, Asthma and Immunology - December 18, 2021 Category: Allergy & Immunology Authors: Afshin Abdi Ghavidel Mahbubeh Rojhannezhad Bahram Kazemi Mojgan Bandehpour Source Type: research

Trilogy of COVID-19: Infection, Vaccination, and Immunosuppression
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative respiratory pathogen responsible for coronavirus disease 2019 (COVID-19). In 2020, the power of open science was visible to all, as novel vaccinology led to rapid establishment of vaccine clinical trials, and subsequent authorization of SARS-CoV-2 at an unprecedented pace. This evoked rapid deployment of SARS-CoV-2 vaccines and booster doses to keep with the ever-changing landscape of SARS-CoV-2. In this review, we provide an overview of vaccine efficacy studies, which have been well characterized in healthy individuals. Nevertheless, vaccine eff...
Source: International Archives of Allergy and Immunology - April 7, 2022 Category: Allergy & Immunology Source Type: research

Rapid Progress in Our Understanding of Covid-19 Vaccine Allergy: A Cause for Optimism, not Hesitancy
Anaphylaxis is a life-threatening condition and when associated with vaccination, leads to vaccine hesitancy. The concerns around vaccine related anaphylaxis have become even more important during the COVID-19 pandemic where the COVID-19 vaccines remain one of our most important tools. While rates of anaphylaxis to COVID-19 vaccines are not significantly different from other vaccines, CDC guidance recommends avoidance of the same COVID-19 vaccine in individuals who had an allergic reaction or are allergic to a COVID-19 vaccine component.
Source: Journal of Allergy and Clinical Immunology - April 7, 2022 Category: Allergy & Immunology Authors: Aleena Banerji, Allison E. Norton, Kimberly G. Blumenthal, Cosby A. Stone, Elizabeth Phillips Source Type: research

Effectiveness of Coronavirus Vaccines against Syndrome Coronavirus 2 (SARS-CoV-2) and Its New Variants
Iran J Allergy Asthma Immunol. 2021 Dec 8;20(6):647-671. doi: 10.18502/ijaai.v20i6.8016.ABSTRACTThe widespread outbreak of coronavirus disease 2019 in late 2019 caused many people worldwide to die or suffer from certain clinical complications even after the recovery. The virus has many social and economic adverse effects. Studies on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have specified that spike, surface glycoprotein antigen, is considered as a major target to stimulate the immune system. This glycoprotein binds to the angiotensin-converting enzyme 2 on the surface of human cells especially lung epit...
Source: Iranian Journal of Allergy, Asthma and Immunology - December 18, 2021 Category: Allergy & Immunology Authors: Afshin Abdi Ghavidel Mahbubeh Rojhannezhad Bahram Kazemi Mojgan Bandehpour Source Type: research

Specific antibody response of 14 common variable immunodeficiency patients to three BNT162b2 mRNA COVID-19 vaccinations
Ann Allergy Asthma Immunol. 2022 Apr 6:S1081-1206(22)00291-5. doi: 10.1016/j.anai.2022.03.035. Online ahead of print.NO ABSTRACTPMID:35398265 | DOI:10.1016/j.anai.2022.03.035
Source: Annals of Allergy, Asthma and Immunology - April 10, 2022 Category: Allergy & Immunology Authors: Nizar Abo-Helo Emad Muhammad Sondus Ghaben-Amara Shai Cohen Source Type: research

Effectiveness of Coronavirus Vaccines against Syndrome Coronavirus 2 (SARS-CoV-2) and Its New Variants
Iran J Allergy Asthma Immunol. 2021 Dec 8;20(6):647-671. doi: 10.18502/ijaai.v20i6.8016.ABSTRACTThe widespread outbreak of coronavirus disease 2019 in late 2019 caused many people worldwide to die or suffer from certain clinical complications even after the recovery. The virus has many social and economic adverse effects. Studies on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have specified that spike, surface glycoprotein antigen, is considered as a major target to stimulate the immune system. This glycoprotein binds to the angiotensin-converting enzyme 2 on the surface of human cells especially lung epit...
Source: Iranian Journal of Allergy, Asthma and Immunology - December 18, 2021 Category: Allergy & Immunology Authors: Afshin Abdi Ghavidel Mahbubeh Rojhannezhad Bahram Kazemi Mojgan Bandehpour Source Type: research

Specific antibody response of 14 common variable immunodeficiency patients to three BNT162b2 mRNA COVID-19 vaccinations
Ann Allergy Asthma Immunol. 2022 Apr 6:S1081-1206(22)00291-5. doi: 10.1016/j.anai.2022.03.035. Online ahead of print.NO ABSTRACTPMID:35398265 | DOI:10.1016/j.anai.2022.03.035
Source: Annals of Allergy, Asthma and Immunology - April 10, 2022 Category: Allergy & Immunology Authors: Nizar Abo-Helo Emad Muhammad Sondus Ghaben-Amara Shai Cohen Source Type: research